Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis

Lee, YS; Lee, JC; Yang, SY; Kim, J; Hwang, JH

Hwang, JH (reprint author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea.

SCIENTIFIC REPORTS, 2019; 9 ():

Abstract

The effectiveness of neoadjuvant therapy (NAT) remains unclear in resectable pancreatic cancer (PC) as compared with upfront surgery (US). The aim of ......

Full Text Link